If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Kennett Square families about 20 minutes away via Route 1 (Baltimore Pike) or Route 52, with both MiSight contact lenses, which are FDA-approved to slow myopia progression, and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, so if anything beyond myopia ever comes up, expert care is already in place.
Kennett Square anchors the southern end of Chester County, the historic borough known as the Mushroom Capital of the World, set along Route 1 near Longwood Gardens. Families from the borough, Kennett Township, Unionville, and the surrounding Brandywine countryside make the roughly 20-minute drive up Route 1 to our West Chester office, often after noticing that a child's glasses keep getting stronger at each visit. That steady climb is precisely what a myopia control plan is meant to slow.
Myopia control is not something you buy off a shelf; it is a years-long plan we measure, adjust, and follow as your child grows. With classroom screens, heavy reading loads, and less daylight time than earlier generations spent, more Kennett Square children are turning nearsighted younger than their parents did. Because Mudgil Eye Associates is a full MD-and-OD practice, a residency-trained pediatric optometrist and a Johns Hopkins fellowship-trained pediatric ophthalmologist share one roof, so anything your child's eyes might require is already covered.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, a pediatric ophthalmologist's expertise is already part of their care.
Nearsightedness looks like a simple matter of needing glasses to read the board, but the real change is structural. In a myopic eye, the eyeball has stretched slightly too long from front to back, a process called axial elongation. Because the eye is too long, light from far away comes to a focus just before the retina instead of on it, leaving distance blurry while close-up remains crisp. Glasses and everyday contacts bend that light back into focus, yet they leave the eye's length, and its growth, untouched. Redirecting that growth is what myopia control sets out to do.
The goal reaches well past a thinner lens at the next checkup. Each added degree of nearsightedness leaves a longer, more stretched eye and raises the lifetime odds of conditions like retinal detachment, glaucoma, earlier cataract, and myopic maculopathy later in life. By slowing how fast the myopia builds during the growing years, we hope to leave your child with a lower adult prescription, and a lower prescription means lower long-term risk. Importantly, myopia control does not cure or reverse the nearsightedness already there, and results vary from child to child, though for most children it slows the pace in a meaningful way.
Childhood myopia is on the rise nationwide, and southern Chester County follows the same trend. Family history matters a great deal, so a child with nearsighted parents faces higher odds from the start, but environment counts too. Long stretches of near focus for schoolwork, reading, and screens, combined with fewer hours outside in daylight, track with faster progression. For a Kennett Square family, one of the simplest evidence-supported moves is protecting regular outdoor time, which is why we treat daily habits as part of the plan, not a side note.
When a Kennett Square child is old enough and ready to wear a contact lens, MiSight 1 day is frequently our first recommendation. It is the only soft contact lens the FDA has approved specifically to slow the progression of myopia in children, and since it is a daily-disposable lens worn during waking hours, it also corrects distance vision while it is worn. Many families find that convenient at school and at practice, and results vary from child to child.
To a child, a MiSight lens feels like an ordinary soft contact, but its design carries concentric treatment zones. The central zone delivers clear distance vision while the outer zones focus some of the light just ahead of the peripheral retina, a signal that seems to calm the eye's push to keep growing longer. In the manufacturer's multi-year clinical trial, children wearing MiSight progressed, on average, far more slowly than a control group, about a 59 percent reduction in the rate of progression over three years. That statistic is a clinical-study result, and the benefit any single child sees will differ.
MiSight is generally a fit for school-age and older children, commonly starting around ages 8 to 12, who are responsible enough to insert, remove, and care for a lens with early help from a parent. Since a fresh lens is used each day and tossed at night, there is no solution or case to keep up with. Significant astigmatism can rule a child out, something Dr. Julakanti evaluates at the fitting. For the lenses to work, they must be worn most of the day, generally ten or more hours a day, six or more days a week, until the eyes finish growing and the prescription holds steady.
Some Kennett Square children are not ready to manage a contact lens, and for them a single nightly eye drop offers an easy path. Low-dose atropine is now among the most widely discussed ways to slow childhood myopia, and for a well-chosen patient it is straightforward and well tolerated. Because it demands so little from the child, it is a common first step with younger patients.
Atropine is a long-standing eye medicine. In the very weak concentrations used for myopia control, typically 0.01% to 0.05%, it is used off-label to slow the eye's lengthening over time. That is a different purpose, at a far lower strength, than the dilating drops used at a comprehensive eye exam, which is why the side effects people associate with atropine tend to be minimal at these small doses.
Simplicity is the draw. A single drop goes in each eye at bedtime, woven into the nighttime routine, and the child wears their normal glasses during the day. Nothing needs to be inserted, cleaned, or stored. Because the concentration is so low, many children notice nothing at all, while a few report slight light sensitivity or a minor change in near focus, which we track and can soften by adjusting the strength.
One reason atropine works well as a managed treatment is that its strength is adjustable. We may start lower and change course depending on how the prescription behaves over the following months. This is not a drop you prescribe and forget; it is a plan our optometric team revisits at each follow-up, tracking both the pace of progression and how easily your child tolerates the drop.
MiSight 1 day lenses and low-dose atropine drops are both proven, evidence-based ways to slow how quickly a child's nearsightedness advances. Neither cures myopia, and neither works the same in every child, so the right choice comes down to your child rather than a rigid formula. Together we weigh age and maturity, the current prescription and how fast it is moving, comfort with wearing a contact, the amount of astigmatism, everyday activities, and your family's own preferences.
Broadly, MiSight fits an older, contact-lens-ready child who is comfortable wearing a lens during the day, while low-dose atropine fits a younger child, a child not yet ready for lenses, or a family that prefers a simple nightly drop with glasses by day. Some children start on one method and change as they mature, and in select cases the two are used together. Whatever we choose, myopia control is a managed plan: we measure the prescription, and where helpful the length of the eye, at regular visits and adjust as we go. Results vary from child to child, and our aim is the best result for yours.
The best moment to begin myopia control is early in the progression, while the eye is still growing and there is more future change left to prevent. In practice that is often the first time a child needs distance glasses, or the first time a prescription jumps between yearly exams. Myopia most often appears between about ages 8 and 12, though it can start earlier, and a Kennett Square child with nearsighted parents or a fast-moving prescription deserves a closer look sooner rather than later. No referral is needed to book an evaluation.
Most nearsighted children are candidates for some form of myopia control. The clearest cues that it is time to ask us include a prescription that rises at every visit, squinting or sitting close to the board or television, frequent headaches or eye strain, or a family history of high myopia. The only way to know which option fits is a full evaluation, and part of our job is to tell you plainly whether myopia control is likely to help your child and which approach makes the most sense.
A myopia control evaluation is a thorough pediatric eye exam, not a quick screening. We measure your child's vision and complete prescription, often with dilating drops for accuracy, check eye alignment and overall eye health, and record baseline measurements so we can follow progression precisely over time. Then we sit down with you and your child, explain the findings in plain language, and lay out the choices, including what each treatment involves day to day, what it can and cannot do, and the follow-up schedule. If a contact lens is the plan, we fit it and teach your child how to handle it. Expect the visit to run a little longer than a comprehensive eye exam, especially when drops are used.
Kennett Square families often appreciate that the first line of defense against worsening nearsightedness can start outside the exam room. Time spent outdoors is one of the most consistently studied lifestyle factors associated with healthier eye development in children, and it pairs naturally with the active, outdoor-friendly lives many families here already lead. A short drive brings them to our West Chester office, where lifestyle is a real part of the conversation, not an afterthought.
Research has consistently linked time spent outdoors with a reduced likelihood of developing myopia and, in some cases, slower progression. A commonly cited target is roughly two hours of outdoor time per day. The leading explanation involves the higher light levels outdoors and the way distance viewing relaxes the eye's near-focus effort, both of which are thought to discourage the excessive eye growth that drives nearsightedness. It is important to frame this as associated with benefit rather than a guaranteed shield, but it is a low-cost, healthy habit worth building.
The two-hour guideline sounds like a lot until you add it up across a day. Outdoor recess, walking or biking instead of riding, weekend time at a park, sports practice, and simply doing homework or reading near a sunny window all count toward the goal. For families in this area, the surrounding parks and open spaces make reaching that target more realistic than it might be elsewhere. The aim is consistency, not intensity.
Lifestyle support also means easing the opposite pressure. Long, unbroken stretches of close-up work are associated with faster progression, so we encourage regular distance breaks, comfortable arm's-length viewing of devices, and good lighting. Outdoor time and reduced near-work strain work together: more of one and less of the other both push in the helpful direction.
Healthy habits are valuable, but they are usually not enough on their own for a child whose eyes are already progressing. When the prescription is climbing, we combine lifestyle guidance with evidence-based treatment such as MiSight 1 day lenses, FDA-approved to slow progression in children roughly ages 8 to 12, or low-dose atropine drops used off-label at bedtime. Dr. Mudgil, board-certified and Johns Hopkins/Wilmer fellowship-trained, and our optometrist help families see where lifestyle ends and medical treatment begins. Slowing progression matters because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child has an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program for Kennett Square families, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and following each child's progress across the years of treatment. Optometrists are the foundation of children's vision care, and Dr. Julakanti's focused pediatric training is exactly what a growing, shifting prescription calls for.
Alongside her is Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having an optometrist and a fellowship-trained pediatric ophthalmologist in the same practice means that if your child ever needs more than myopia control, from a tricky prescription to eye misalignment or a medical concern, that expertise is already on the team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the Kennett Square area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. Kennett Square-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control is most effective when it starts early, while the eye is still growing and the most future change can still be prevented. Many Kennett Square children begin between roughly ages 6 and 12, often at the first sign a prescription is rising, though there is no single correct age. Because the aim is to limit future change, an earlier start generally leads to a lower final prescription. If your child is newly nearsighted or the numbers keep moving, it is worth an evaluation now rather than later.
No. Myopia control neither cures nearsightedness nor reverses the prescription your child already has. Its purpose is to slow how fast the myopia progresses through the growing years, so your child finishes less nearsighted than they otherwise would. Your child will still wear glasses or contacts to see clearly, and results vary from child to child.
Neither wins for every child; the right fit depends on yours. MiSight 1 day lenses suit an older, contact-lens-ready child who is comfortable wearing a lens during the day. Low-dose atropine, a simple nightly drop with glasses by day, suits younger children or those not ready for contacts. Both are evidence-based and proven to slow progression, and Dr. Julakanti helps you choose based on age, prescription, comfort with lenses, and lifestyle.
It helps as a supportive habit. Time outdoors in daylight is associated with a lower chance of developing myopia and, in some studies, slower progression, with roughly two hours a day a commonly cited target. It is not a guarantee and does not replace treatment once a child is progressing, but it is a healthy, low-cost habit we encourage alongside any lens or drop.
For most children it meaningfully slows the rate of progression, though it neither stops it completely nor reverses existing nearsightedness. In its multi-year clinical study, MiSight was associated with about a 59 percent reduction in the rate of progression over three years, and low-dose atropine has slowed progression across multiple studies. These are clinical-study findings; the benefit to any individual child varies, which is why we monitor and adjust at regular visits.
Yes. Myopia control usually suits active Kennett Square kids well. MiSight 1 day lenses are worn during the day and correct distance vision while they are worn, which many children prefer on the field, and each lens is discarded at night. Low-dose atropine is a bedtime drop, so it never gets in the way of daytime activity; the child simply wears their usual glasses or sports eyewear. We are happy to discuss protective eyewear for your child's sport. Results vary from child to child.
Low-dose atropine is used off-label for myopia control; the low concentrations involved, commonly 0.01% to 0.05%, have a long history in eye care and are generally very well tolerated. MiSight, by contrast, is FDA-approved specifically to slow myopia progression in children. Most children on atropine have no side effects, and the few who do usually notice only mild light sensitivity or a slight effect on near focus, which we can manage by adjusting the concentration.
You do not need a referral to schedule a myopia evaluation. Coverage for myopia control varies by plan, and some services or materials may not be covered by medical insurance, so our team reviews the details with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will help you understand the options.
Most Kennett Square families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.